Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 3Gynecologic 1Dermatologic 1

Conditions

Neuroblastoma 8Prostatic Neoplasms 3Precancerous Conditions 3Glioma 3Astrocytoma 3Adenomatous Polyposis Coli 3Skin Neoplasms 2Sarcoma, Ewing 2Osteosarcoma 2Glioblastoma 2Colorectal Neoplasms 2Carcinoma, Basal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Rhabdoid Tumor 1Osteosarcoma Recurrent 1Oligodendroglioma 1Non-melanoma Skin Cancer 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Follicular 1Lung Neoplasms 1Keratosis, Actinic 1Gastritis, Atrophic 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Peripheral Blood Stem Cell Transplantation 9Cyclophosphamide 9Biopsy 8fludarabine phosphate 7Whole-Body Irradiation 6Tacrolimus 5Mycophenolic Acid 5Epoetin Alfa 5Colposcopy 5Celecoxib 5Busulfan 5Aminolevulinic Acid 5Sulindac 4Selenium 4Methotrexate 4Melphalan 4Cyclosporine 4Cetuximab 4Antilymphocyte Serum 4Polymerase Chain Reaction 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Gene Expression Profiling 3Etoposide 3Eflornithine 3Darbepoetin alfa 3Carboplatin 3Aspirin 3fludarabine 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Precancerous Conditions × Eflornithine × Clear all
NCT00006079 2018-10-25

Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia

M.D. Anderson Cancer Center

Phase 2 Completed
150 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed
DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

NCT00118365 2015-01-22

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

National Cancer Institute (NCI)

Phase 3 Completed
375 enrolled 27 charts
Other neoplasm

Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡